Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders.
The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,400 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb.
Esteya electronic brachytherapy is a form of high dose rate (HDR) brachytherapy that brings an electronic brachytherapy source in close proximity to the cancerous site. Its direct delivery enables Esteya to focus more therapeutic radiation on the disease target and to minimize radiation to surrounding tissues and organs.
Patient-friendly treatment helps minimize radiation exposure to healthy tissues.
Comprehensive, customer adapted service programs that guarantee precision and maximise utilization.
Precise solutions for brachytherapy treatment.
Providing human-centric software solutions to improve workflow and patient care.